Canadian Study Suggests Drug-Eluting Stents May Improve Long-Term Survival
This article was originally published in The Gray Sheet
Executive Summary
Drug-eluting stents may provide a long-term mortality benefit over bare-metal stents for at least some patients, according to a Canadian registry study in the Oct. 4 New England Journal of Medicine
You may also be interested in...
Drug-Eluting-Stent Market Penetration At Nadir? Rebound Forecast At TCT
U.S. drug-eluting-stent market penetration reached an all-time low in September, but clinicians meeting last week in Washington, D.C., are confident new data will help to reverse the trend that began just over a year ago
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.